Patent ID: 9192612
Filing Date: 2015-11-24
Classification: A61K,A61P,C07D

Abstract:
1. A method of treating Alzheimer's disease in a patient, the method comprising administering a therapeutically effective amount of a-compound of Formula I wherein R R R wherein said C 1-6 alkyl, C 1-6 alkoxy or C 1-6 alkoxy-C 1-6 alkyl are each optionally substituted with one to three fluoro and wherein said C 3-6 cycloalkyl, C 3-6 cycloalkoxy and (4- to 6-membered heterocycloalkyl) moieties are optionally substituted with one to three substituents independently selected from the group consisting of fluoro, methyl, fluoromethyl, difluoromethyl or trifluoromethyl; R heterocycloalkyl); wherein said C R m at each occurrence is independently 0, 1 or 2; and n is 1, 2 or 3; or a tautomer thereof or a pharmaceutically acceptable salt of said compound or tautomer; to a patient in need of treatment thereof.